Health Impact

Health impact is a vital element in the scope of the Sustainable Development Goals (SDGs). The term "health impact" refers to the effect of a specific action, policy, or environmental change on the health of individuals and communities. It is widely used in health impact assessments, which aim to predict the potential health outcomes of a proposed policy or project.

With reference to the SDGs, health impact is chiefly aligned with SDG 3: "Ensure healthy lives and promote well-being for all at all ages". This goal envisages a world where every individual has access to quality healthcare services and lives devoid of preventable diseases. Such a scenario necessitates careful consideration and evaluation of the health impacts of all developmental policies, programs, and interventions.

However, the relevance of health impact extends beyond SDG 3. For example, the implementation of SDG 11: "Make cities and human settlements inclusive, safe, resilient, and sustainable" can have a significant health impact. By promoting sustainable urban planning, we can reduce air pollution, promote physical activity, and decrease mental stress, thereby positively affecting public health.

Similarly, the realization of SDG 6: "Ensure availability and sustainable management of water and sanitation for all" directly influences the health impact by reducing waterborne diseases and improving hygiene. SDG 2: "End hunger, achieve food security and improved nutrition and promote sustainable agriculture" also has direct health impacts by improving nutritional outcomes.

Elsevier,

Clinical Neuroepidemiology of Acute and Chronic Disorders, First Edition, 2023, pp 199-211

This chapter advances the UN SDG goals 3 and 17 by reviewing the basics understandings of delirium and dementia.
Elsevier,

Medicinal Usage of Cannabis and Cannabinoids, First Edition, 2023, pp 129-134

This chapter advances the UN SDG goals 3 and 17 by reviewing the use of cannabidiol oil for AD patients.
Elsevier,

COVID-19 in Alzheimer's Disease and Dementia, First Edition, 2023, pp 203-214

This chapter advances the UN SDG goals 3 and 17 discusses the effects COVID had on the lifestyle of patients with AD.
This chapter advances the UN SDG goal 3 and 17 by exploring antiogensin in relation to the treatment of neurological disorders
Elsevier,

COVID-19 in Alzheimer's Disease and Dementia, First Edition, 2023, pp 259-271

This chapter advances the UN SDG goals 3 and 17 discusses the female gender on AD risk.
Elsevier,

Handbook of Animal Models in Neurological Disorders, First Edition, 2022, pp 31-41

This chapter advances the UN SDG goals 3 and 17 presenting the current mouse models to studying AD.
This chapter advances the UN SDG goals 3 and 17 by presenting how studying zebrafish and behavioral models and molecular markers in the study of AD.
Elsevier,

Oxidative Stress: Its Mechanisms and Impacts on Human Health and Disease Onset, 2023, Pages 291-297

This chapter advances the UN SDG goal 3 and 17 by discussing how Alzheimer's disease risk factors, as well as the mechanism for onset and progression, are related to elevated oxidative stress.
Elsevier,

Plant Extracts in Neurodegenerative Diseases, First Edition, 2022, pp 1-15

This chapter advances the UN SDG goals 3 and 17 discusses how plant extracts can help decrease AD symptoms.
Elsevier,

Autophagy Dysfunction in Alzheimer's Disease and Dementia, First Edition, 2022, pp 73-89

This chapter advances the UN SDG goals 3 and 17 discusses the links of Amyloid β(Aβ) to AD.

Pages